Squamous cell carcinoma of the skin screening: Difference between revisions
No edit summary |
|||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Revision as of 15:08, 11 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Squamous cell carcinoma of the skin Microchapters |
|
Differentiating Squamous cell carcinoma of the skin from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Squamous cell carcinoma of the skin screening On the Web |
|
American Roentgen Ray Society Images of Squamous cell carcinoma of the skin screening |
|
Directions to Hospitals Treating Squamous cell carcinoma of the skin |
|
Risk calculators and risk factors for Squamous cell carcinoma of the skin screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
Screening
Since Squamous cell carcinoma is almost always cured without specified screening no studies have shown that such screening will improve the already high cure rates for this type of skin carcinoma. For carcinoma of prostrate, prostrate specific antigen (PSA) is often used for diagnosis. Squamous cell carcinoma of prostrate is very aggressive in nature. It is difficult to detect as there is no increase in prostate specific antigen levels seen; meaning that the cancer is often diagnosed at an advanced stage.